An observational study in Postoperative Complications, sponsored by Huazhong University of Science and Technology. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-07-06.
Sponsored by Huazhong University of Science and Technology · Observational
The investigators aimed to investigate postoperative complications associated with Swan-Ganz Catheter based on the clinical data of Wuhan Union Hospital and Wuhan Asian heart hospital for 10 years, including major cardiovascular, respiratory adverse events, ICU time, mechanical ventilation time, length of hospital stay, in-hospital mortality, and 30-day postoperative mortality events.
1,235 studies on the registry are indexed under Postoperative Complications; 294 are open to participants now.
This study's planned enrollment of 3,000 is above the median of 253 across 521 observational studies indexed under Postoperative Complications.
Browse Postoperative Complications studies →Huazhong University of Science and Technology is the lead sponsor of 242 studies on the registry; 61 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Adults undergoing cardiac surgery
Exclusion Criteria:
Swan-Ganz Catheter
Number of participants with cardiovascular events
1) Cardiac death; 2) Non fatal myocardial infarction; 3) Intra aortic balloon counterpulsation (IABP); 4) Thoracotomy exploration; 5) Heart failure.
Time frame: one week after operation
Number of participants respiratory adverse events
1) Acute lung injury: Diagnosis according to Berlin diagnostic standard; 2) Atelectasis: X-ray confirmed with body temperature \>37.5c or abnormal pulmonary manifestations; 3) Pneumothorax: chest X-ray diagnosis; 4) Pneumonia: confirmed by radiology or bacteriology
Time frame: one week after operation
No study locations are listed for this record.
Plan to share: Undecided — If the patient's privacy information is not involved, you can contact the research team by email to obtain data (yaoshanglong@hust.edu.cn)
No publications or documents are linked to this record.
This study is not yet recruiting, as verified in Jun 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Huazhong University of Science and Technology